|

Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

RECRUITINGSponsored by Peking Union Medical College Hospital
Actively Recruiting
SponsorPeking Union Medical College Hospital
Started2022-04-29
Est. completion2024-11-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06417502

Summary

An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Age \<= 18 years old
* Diagnosed with rheumatic and immunologic diseases (including diffuse connective tissue diseases, arthritis, vasculitis, inborn errors of immunity)
* Diagnosed and Treated in China

Exclusion Criteria:

* Disagreement of involving in this study by the patient or his/her family.

Conditions4

ArthritisAutoimmune DiseasesAutoinflammatory DiseasesLupus

Browse More Trials

Arthritis trialsLupus trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.